Michael Secora

Insider Reports History

Location
Salt Lake City, UT
Signature
/s/Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Michael Secora:

Company Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Class A Common Stock 1,487,694 $9,186,510 $6.18 15 Nov 2024 Direct
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 348,380 15 Nov 2024 Direct

Insider Reports Filed by Michael Secora

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RXRX RECURSION PHARMACEUTICALS, INC. 15 Nov 2024 1 -$73,711 4 Chief Financial Officer 19 Nov 2024, 18:26
RXRX RECURSION PHARMACEUTICALS, INC. 12 Nov 2024 6 -$54,680 4 Chief Financial Officer 14 Nov 2024, 19:19
RXRX RECURSION PHARMACEUTICALS, INC. 08 Oct 2024 6 -$15,306 4 Chief Financial Officer 10 Oct 2024, 18:40
RXRX RECURSION PHARMACEUTICALS, INC. 10 Sep 2024 6 -$12,404 4 Chief Financial Officer 12 Sep 2024, 18:28
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2024 1 -$80,026 4 Chief Financial Officer 19 Aug 2024, 19:09
RXRX RECURSION PHARMACEUTICALS, INC. 13 Aug 2024 6 -$15,609 4 Chief Financial Officer 15 Aug 2024, 17:24
RXRX RECURSION PHARMACEUTICALS, INC. 09 Jul 2024 6 -$43,528 4 Chief Financial Officer 11 Jul 2024, 16:51
RXRX RECURSION PHARMACEUTICALS, INC. 13 Jun 2024 6 -$104,055 4 Chief Financial Officer 17 Jun 2024, 17:46
RXRX RECURSION PHARMACEUTICALS, INC. 15 May 2024 1 -$119,740 4 Chief Financial Officer 17 May 2024, 19:11
RXRX RECURSION PHARMACEUTICALS, INC. 16 Apr 2024 6 -$200,507 4 Chief Financial Officer 18 Apr 2024, 17:12
RXRX RECURSION PHARMACEUTICALS, INC. 12 Mar 2024 6 -$370,690 4 Chief Financial Officer 14 Mar 2024, 19:28
RXRX RECURSION PHARMACEUTICALS, INC. 15 Feb 2024 1 -$89,148 4 Chief Financial Officer 16 Feb 2024, 19:59
RXRX RECURSION PHARMACEUTICALS, INC. 13 Feb 2024 7 -$341,485 4 Chief Financial Officer 15 Feb 2024, 18:00
RXRX RECURSION PHARMACEUTICALS, INC. 09 Feb 2024 4 -$25,346 4 Chief Financial Officer 13 Feb 2024, 19:01
RXRX RECURSION PHARMACEUTICALS, INC. 16 Jan 2024 6 -$351,008 4 Chief Financial Officer 18 Jan 2024, 18:37
RXRX RECURSION PHARMACEUTICALS, INC. 12 Dec 2023 6 -$208,138 4 Chief Financial Officer 14 Dec 2023, 18:53
RXRX RECURSION PHARMACEUTICALS, INC. 14 Nov 2023 8 -$225,924 4 Chief Financial Officer 16 Nov 2023, 18:54
RXRX RECURSION PHARMACEUTICALS, INC. 10 Oct 2023 6 -$181,575 4 Chief Financial Officer 12 Oct 2023, 18:07
RXRX RECURSION PHARMACEUTICALS, INC. 12 Sep 2023 6 -$261,450 4 Chief Financial Officer 14 Sep 2023, 18:26
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2023 7 -$331,251 4 Chief Financial Officer 17 Aug 2023, 18:35
RXRX RECURSION PHARMACEUTICALS, INC. 18 Jul 2023 9 -$562,650 4 Chief Financial Officer 19 Jul 2023, 19:07
RXRX RECURSION PHARMACEUTICALS, INC. 13 Jun 2023 6 -$333,645 4 Chief Financial Officer 15 Jun 2023, 19:28
RXRX RECURSION PHARMACEUTICALS, INC. 15 May 2023 1 -$26,656 4 Chief Financial Officer 17 May 2023, 18:17
RXRX RECURSION PHARMACEUTICALS, INC. 15 Feb 2023 1 -$10,618 4 Chief Financial Officer 17 Feb 2023, 16:15
RXRX RECURSION PHARMACEUTICALS, INC. 01 Feb 2023 4 -$22,820 4 Chief Financial Officer 03 Feb 2023, 16:14
RXRX RECURSION PHARMACEUTICALS, INC. 15 Nov 2022 1 -$12,631 4 Chief Financial Officer 17 Nov 2022, 17:45
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2022 1 -$13,802 4 Chief Financial Officer 17 Aug 2022, 18:33
RXRX RECURSION PHARMACEUTICALS, INC. 16 May 2022 1 -$6,061 4 Chief Financial Officer 18 May 2022, 19:17
RXRX RECURSION PHARMACEUTICALS, INC. 04 Feb 2022 3 -$7,729 4/A Chief Financial Officer 28 Apr 2023, 16:30

Sponsored